Bone Metastases Detection in Patients with Breast Cancer: Does Bone Scintigraphy Add Information to PET/CT?
The Oncologist · 2023
DOI: 10.1093/oncolo/oyad087 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2023. Verfasst von Joana Cristo Santos und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Coimbra, CISUC, Department of Informatics Engineering, Coimbra 3030-290, Portugal. Hauptthemen laut MEDLINE: Breast Neoplasms, Bone Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Science and Technology, National Funds, Portuguese Institute of Oncology of Porto Francisco Gentil.
Abstract (Originalsprache)
Background
Positron emission tomography/computed tomography (PET/CT) has become in recent years a tool for breast cancer (BC) staging. However, its accuracy to detect bone metastases is classically considered inferior to bone scintigraphy (BS). The purpose of this work is to compare the effectiveness of bone metastases detection between PET/CT and BS. Materials and Methods Prospective study of 410 female patients treated in a Comprehensive Cancer Center between 2014 and 2020 that performed PET/CT and BS for staging purposes. The image analysis was performed by 2 senior nuclear medicine physicians. The comparison was performed based on accuracy, sensitivity, and specificity on a patient and anatomical region level and was assessed using McNemar’s Test. An average ROC was calculated for the anatomical region analysis.
Results
PET/CT presented higher values of accuracy and sensitivity (98.0% and 93.83%), surpassing BS (95.61% and 81.48%) in detecting bone disease. There was a significant difference in favor of PET/CT (sensitivity 93.83% vs. 81.48%), however, there is no significant difference in eliminating false positives (specificity 99.09% vs. 99.09%). PET/CT presented the highest accuracy and sensitivity values for most of the bone segments, only surpassed by BS for the cranium. There was a significant difference in favor of PET/CT in the upper limb, spine, thorax (sternum) and lower limb (pelvis and sacrum), and in favor of BS in the cranium. The ROC showed that PET/CT has a higher sensitivity and consistency across the bone segments.
Conclusion
With the correct imaging protocol, PET/CT does not require BS for patients with BC staging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Coimbra, CISUC, Department of Informatics Engineering, Coimbra 3030-290, Portugal.
- Department of Medical Oncology, Portuguese Institute of Oncology of Porto Francisco Gentil, EPE, Porto, Portugal.
- Department of Nuclear Medicine, Portuguese Institute of Oncology of Porto Francisco Gentil, EPE, Porto, Portugal.
ORCID-Profile: Joana Cristo Santos
Förderung
- Foundation for Science and Technology
- National Funds
- Portuguese Institute of Oncology of Porto Francisco Gentil
- Portuguese Funding Institution Foundation for Science and Technology
Zitieren
APA
Cristo Santos, J., Henriques Abreu, M., Seoane Santos, M., Duarte, H., Alpoim, T., Próspero, I., Sousa, S., & Henriques Abreu, P. (2023). Bone Metastases Detection in Patients with Breast Cancer: Does Bone Scintigraphy Add Information to PET/CT?. The Oncologist. https://doi.org/10.1093/oncolo/oyad087
Vancouver
Cristo Santos J, Henriques Abreu M, Seoane Santos M, Duarte H, Alpoim T, Próspero I, et al. Bone Metastases Detection in Patients with Breast Cancer: Does Bone Scintigraphy Add Information to PET/CT?. The Oncologist. 2023. doi:10.1093/oncolo/oyad087
BibTeX
@article{CristoSantos2023,
author = {Cristo Santos, Joana and Henriques Abreu, Miguel and Seoane Santos, Miriam and Duarte, Hugo and Alpoim, Tiago and Próspero, Inês and Sousa, Susana and Henriques Abreu, Pedro},
title = {Bone Metastases Detection in Patients with Breast Cancer: Does Bone Scintigraphy Add Information to PET/CT?},
journal = {The Oncologist},
year = {2023},
doi = {10.1093/oncolo/oyad087}
}
EUVIMED